Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

15. Mai 2020 08:00 ET | Quelle: Biotheranostics, Inc.

Biotheranostics’ Breast Cancer Index® predicts benefit from two-and-a-half versus five years of extended endocrine therapy in HR+ breast cancer patients treated in the IDEAL trial

San Diego, CA, May 15, 2020 (GLOBE NEWSWIRE) -- Novel evidence demonstrating the ability of Breast Cancer Index to predict preferential endocrine response in distinct subgroups of HR+ early stage...
11. Dezember 2019 08:00 ET | Quelle: Biotheranostics, Inc.

Biotheranostics Launches Not Another Minute Campaign for its Breast Cancer Index® Test

San Diego, CA, Dec. 11, 2019 (GLOBE NEWSWIRE) -- Biotheranostics, Inc., announces the launch of its Not Another Minute campaign, revealing how Breast Cancer Index (BCI) is changing the game for...
10. September 2013 09:58 ET | Quelle: The BC5 Project

Introducing The BC5 Project: New Initiative to Empower Women to Explore All Breast Cancer Treatment Options

NEW YORK, Sept. 10, 2013 (GLOBE NEWSWIRE) -- In an effort to ensure that all women diagnosed with early stage breast cancer are well-informed about their treatment options, a new group called The BC5...